Arcadia Biosciences Q2 EPS $0.61 Beats $(4.80) Estimate, Sales $1.39M Miss $1.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Arcadia Biosciences reported Q2 earnings of $0.61 per share, beating the analyst consensus estimate of $(4.80) by 112.71%. However, the company's quarterly sales of $1.39 million missed the analyst consensus estimate of $1.82 million by 23.68%. This represents a 64.00% decrease over sales of $3.86 million the same period last year.
August 10, 2023 | 9:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Arcadia Biosciences' Q2 earnings beat estimates but sales missed, indicating mixed financial performance.
Arcadia Biosciences' earnings beat estimates, which is positive for the stock. However, the company's sales missed estimates, which is negative. These two factors could offset each other, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100